.-The aim of this study was to determine the effect of high levels of free fatty acids (FFA) and/or hyperglycemia on hepatic glycogenolysis and gluconeogenesis. Intralipid was infused peripherally in 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence (FFA ϩ HG) or absence (FFA ϩ EuG) of hyperglycemia. In the control studies, Intralipid was not infused, and euglycemia (EuG) or hyperglycemia (HG) was maintained. Insulin and glucagon were clamped at basal levels in all four groups. The arterial blood glucose level increased by 50% in the HG and FFA ϩ HG groups. It did not change in the EuG and FFA ϩ EuG groups. Arterial plasma FFA increased by ϳ140% in the FFA ϩ EuG and FFA ϩ HG groups but did not change significantly either in the EuG or HG groups. Arterial glycerol levels increased by ϳ150% in both groups. Overall (3-h) net hepatic glycogenolysis was 196 Ϯ 26 mg/kg in the EuG group. It decreased by 96 Ϯ 20, 82 Ϯ 16, and 177 Ϯ 22 mg/kg in the HG, FFA ϩ EuG, and FFA ϩ HG groups, respectively. Overall (3-h) hepatic gluconeogenic flux was 128 Ϯ 22 mg/kg in the EuG group, but it was suppressed by 30 Ϯ 9 mg/kg in response to hyperglycemia. It was increased by 59 Ϯ 12 and 56 Ϯ 10 mg/kg in the FFA ϩ EuG and FFA ϩ HG groups, respectively. In conclusion, an increase in plasma FFA and glycerol significantly inhibited hepatic glycogenolysis and markedly stimulated hepatic gluconeogenesis.free fatty acid; hyperglycemia; glycogenolysis; gluconeogenesis AN INCREASE IN FREE FATTY ACIDS (FFA) stimulates hepatic gluconeogenesis (10,14,37). In vitro studies have shown that perfusion of rat liver with lipid increases gluconeogenesis (36,37) and that an increase in FFA oxidation stimulates the activities of key enzymes in the gluconeogenic pathway (3,26). In accord with this, Boden and Jadali (5) reported that a rise in plasma FFA increased hepatic glucose production (HGP) in normal human subjects. In addition, Saloranta et al. (30) showed that an increase in FFA and glycerol availability, brought about by Intralipid infusion, increased gluconeogenesis and glucose production in type 2 diabetic patients. In contrast, in a recent study, Roden et al. (27) did not detect a change in HGP in response to an increase in FFA in normal humans. Likewise, Johnston et al. (18) reported that an acute increase in the plasma FFA level did not change HGP in type 2 diabetic subjects. In agreement with the latter, Puhakainen and colleagues (24,25) showed that a decrease in plasma FFA, although it reduced gluconeogenesis, did not change HGP in patients with type 2 diabetes. Most recently, Boden et al. (4) showed in both normal and type 2 diabetic subjects that increasing and decreasing plasma FFA stimulated and inhibited gluconeogenesis, respectively, but did not alter glucose production. In another recent study, Stingl et al. (35) showed that in normal humans HGP and glycogenolysis both decreased in response to an increase in plasma FFA level. It is obvious from the above discordance that the effect of an increase in FFA av...